Onaiza Cadoret-Manier - 15 Jan 2023 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
EVP, Chf GL Pdt Str & Oper Ofc
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Onaiza Cadoret-Manier
Issuer symbol
IONS
Transactions as of
15 Jan 2023
Net transactions value
$0
Form type
4
Filing time
18 Jan 2023, 19:17:45 UTC
Previous filing
12 Jan 2023
Next filing
19 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Performance Restricted Stock Units Award $0 +16,216 +131% $0.000000 28,635 15 Jan 2023 Common Stock 16,216 $0.000000 Direct F1, F2
transaction IONS Restricted Stock Unit Award $0 +19,460 +42% $0.000000 65,523 15 Jan 2023 Common Stock 19,460 $0.000000 Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to reporting person of Performance Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
F2 Represents an award of performance based restricted stock units ("PRSUs"). The PRSUs may vest at the end of the three-year performance period following the date of grant based on the Issuer's relative total shareholder return as compared to a peer group of companies. The number of PRSUs reported represents the maximum that may be earned, which is 200% of the target number. No number of PRSUs is guaranteed to vest and the actual number of PRSUs that will vest at the end of the performance period may be anywhere from zero to the amount stated.
F3 Grant to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan.
F4 Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
F5 Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.